| Date Filed | Type | Description |
| 06/09/2023 |
4
| Eisner Mark (EVP, Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 2,042 shares
@ $17.038, valued at
$34.8k
|
|
| 06/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/06/2023 |
4
| Eisner Mark (Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 9,182 shares
@ $18.7838, valued at
$172.5k
|
|
| 03/10/2023 |
4
| Eisner Mark (Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 7,363 shares
@ $21.1559, valued at
$155.8k
Granted 7,732 shares
@ $0
Granted 12,451 shares
@ $0
Sold 3,885 shares
@ $20.1973, valued at
$78.5k
Sold 6,255 shares
@ $20.1973, valued at
$126.3k
|
|
| 03/06/2023 |
4
| Eisner Mark (Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 1,187 shares
@ $21.87, valued at
$26k
|
|
| 02/23/2023 |
4
| Eisner Mark (Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 32,500 shares
@ $0
Granted 55,000 options to buy
@ $22.6, valued at
$1.2M
|
|
| 12/02/2022 |
4
| Eisner Mark (Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 1,084 shares
@ $15.04, valued at
$16.3k
|
|
| 10/04/2022 |
4
| Eisner Mark (Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 6,777 shares
@ $13.01, valued at
$88.2k
|
|
| 09/02/2022 |
4
| Eisner Mark (Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 756 shares
@ $13.09, valued at
$9.9k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| Eisner Mark (Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 60,000 shares
@ $0
Granted 100,000 options to buy
@ $15.6, valued at
$1.6M
|
|
| 01/05/2022 |
4
| Eisner Mark (Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 7,043 shares
@ $14.82, valued at
$104.4k
|
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2020 |
4
| Eisner Mark (Incoming Chief Medical Officer) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 35,000 shares
@ $0
Granted 80,000 options to buy
@ $41.25, valued at
$3.3M
|
|
| 12/03/2020 |
3
| Eisner Mark (Incoming Chief Medical Officer) has filed a Form 3 on FIBROGEN INC |